CES2 and hepatocellular carcinoma: At single-cell level, HCC cells exhibiting high SPINK1 expression demonstrate resistance to therapy through an active drug metabolic signaling pathway, a process facilitated by the histological co-expression of SPINK1 with CES2 and CYP3A5.